GlassScriptPhysician profile
Ashu Syal
NPI 1124064779
$1,311.09
in general payments reported to CMS, 2019-2025
19 companies · $373 in 2025
The $373 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.80 · 2020: $43.93 · 2021: $95.64 · 2022: $210 · 2023: $178 · 2024: $332 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $226.17 | 2022-2025 | Qelbree |
| Pfizer INC. | $199.05 | 2023-2025 | |
| Abbott Laboratories | $167.30 | 2022-2024 | Freestyle Libre 3 |
| Cumberland Pharmaceuticals, INC. | $115.02 | 2020-2023 | Kristalose |
| Sanofi Pasteur INC. | $70.97 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $64.05 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $63.37 | 2019-2025 | Enflonsia, Vaxneuvance |
| Tris Pharma INC | $54.82 | 2024 | Onyda Xr |
| Boston Scientific Corporation | $51.91 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.83 | 2023 | |
| Hologic Sales and Service, LLC | $51.07 | 2019-2025 | Aptima |
| Seqirus USA INC | $47.42 | 2024-2025 | Flucelvax |
| Cranial Technologies, INC | $41.69 | 2019-2023 | Doc Band |
| Glaxosmithkline, LLC. | $29.44 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.35 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $16.44 | 2024 | Niox |
| Tempus Ai, INC | $15.54 | 2025 | Tempus Pixel |
| Lilly USA, LLC | $13.57 | 2023 | Jardiance |
| Dexcom, INC. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashu Syal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.